AMA Prévention: on-site audit, expertise, and screening

Based in Strasbourg, AMA Prévention supports professionals, communities, and individuals across France in choosing and deploying screening, prevention, and security solutions adapted to risks related to drugs, alcohol, and chemical submission.

Partnership with Toda Pharma laboratory

AMA Prévention supports the deployment of Drugdiag® screening solutions developed by the French laboratory Toda Pharma. This collaboration offers devices manufactured under an ISO 13485 certified quality system, with full traceability and scientific expertise adapted to field challenges.

Whether for road safety, occupational health, or the fight against chemical submission, we turn laboratory expertise into concrete and accessible prevention solutions.

Our Commitments

Screening & Compliance

Audit, secure, and document risk positions, fleets, and sensitive sites.

  • Saliva and urine tests compliant with official thresholds.
  • Simultaneous multi-drug detection.
  • DUERP and Plan Joana 2025 compliance.
  • Deployment possible through device purchase or on-site mobile intervention.

Expert Audit & Advice

Structuring an alcohol, drug, and prevention policy truly applicable in the field.

  • Audit of practices, sensitive positions, and internal procedures.
  • Consultation on internal regulations, DUERP, Plan Joana, and screening protocols.
  • On-site mobile screening with a confidential and reassuring framework.
  • Direct access to our prevention, field, and toxicology expertise.

Field Action

Building trust with audiences and teams in sensitive environments.

  • GHB & Ketamine detection devices.
  • Field devices for festivals, communities, ERP, and events.
  • Population protection protocols.
  • Confidential, clear, and non-stigmatizing approach.
🚀

Need a clear framework quickly?

In case of sensitive sites, accidents, internal tensions, or regulatory requests, AMA Prévention helps you set a framework: quick audit, expert consultation, selection of suitable devices, and possibility of on-site mobile intervention.